AEON Biopharma, Inc. (AEON)
PHARMACEUTICAL PREPARATIONS
AEON Biopharma, Inc. (AEON) is listed on NYSE American, where it has traded since July 24, 2023.
- Listed On
- NYSE American
- Listed Since
- July 24, 2023
- Employees
- 8
- Market Cap
- $13M
About AEON Biopharma, Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 21 institutions reported holding AEON, with 12.8 million shares worth $9.2 million in aggregate. The largest reported holder was Dauntless Investment Group, with 12.5 million shares worth $9.0 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Dauntless Investment Group | 12,490,154 | $9M | Added 394.12% |
| Vanguard | 104,242 | $75K | Reduced 0.94% |
| Geode Capital Management | 95,311 | $69K | Added 9.47% |
| Blue Owl Capital Holdings | 42,353 | $30K | Unchanged |
| Formidable Asset Management | 20,024 | $20K | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AEON?
AEON Biopharma, Inc. (AEON) is listed on NYSE American, where it has traded since July 24, 2023.
Who are the largest institutional holders of AEON?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AEON were Dauntless Investment Group, Vanguard and Geode Capital Management.
How many institutions own AEON?
21 institutions reported a position in AEON for the quarter ended June 30, 2026, worth $9.2 million in total.
Did institutions buy or sell AEON last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for AEON.
Every reported institutional holder, plus insider and congressional trades in AEON, on SentiSense.